Berikut ini adalah laporan asli hasil study dr. Denise Louise Faustman, MD, di MASSACHUSETT GENERAL HOSPITAL dalam percobaan pemberian vaksin BCG / BACILLUS CALMETTE GUERIN terhadap 150 pasien ( mulai 18 tahun - 65 tahun) dengan diagnosa DIABETES type 1 dengan prosedur 2 dosis suntikan ke-1 dan pemberian 2 dosis suntikan ke-2 dalam selang waktu 30 - 37 hari kemudian.

FAKTA LAPORAN :
Perbaikan kualitas HbA1c, KUALITAS DAYA TAHAN TUBUH & KUALITAS GINJAL mulai tahun ke 1, 2, 3 s/d 5 tahun kemudian

DATA ASLI hasil penelitian

EXPERIMENTAL :
2 BCG vaccinations spaced 4 weeks apart during the first year and then 1 vaccination every year for the next 4 years

OUTCOME
1. Primary Outcome Measures : IMPROVEMEN in HbA1c [ Time Frame: 1, 2, 3, 4, and 5 years after initial BCG/placebo injection ] Improvement in the hemoglobin A1c (HbA1c) measurement compared to self

2. Seondary Outcome Measures : CHANGE IN IMMUNE RESPONSE [ Time Frame: 2 and 4 weeks and 1, 2, 3, 4, and 5 years after initial BCG/placebo injection ] beneficial immune changes of autoimmune reversal that may also lead to a change in insulin

3. Outcome Measures: STABILIZATION IN URINARY C-peptide [ Time Frame: 1, 2, 3, 4, and 5 years after initial BCG/placebo injection ] stabilization or improvement in urinary c-peptide of BCG treated group as compared to placebo group or self

4. Stablization of STIMULATED C-peptide [ Time Frame: 1, 2, 3, 4, and 5 years after initial BCG/placebo injection ] improvement or stabilization in stimulated C-peptide (self insulin) as measured by a mixed meal tolerance test (MMTT) when compared to self or placebo treated group

terlampir SUMBER ASLI
https://clinicaltrials.gov/ct2/show/NCT02081326